FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

CRYO CELL INTERNATIONAL INC

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/13/2018 

3. Issuer Name and Ticker or Trading Symbol

Cord Blood America, Inc. [CBAI]

(Last)        (First)        (Middle)

700 BROOKER CREEK BLVD., SUITE 1800, 

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

OLDSMAR, FL 34677       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   114207446   (1) (5) D    
Common Stock   16268554   (2) (5) D    
Common Stock   4061770   (3) (5) D    
Common Stock   25000000   (4) (5) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Shares owned solely by CRYO-CELL International, Inc.
(2)  Shares owned solely by David I. Portnoy.
(3)  Shares owned solely by Mark L. Portnoy.
(4)  Shares owned solely by George Gaines.
(5)  Messrs. Portnoy, Portnoy and Gaines, along with CRYO-CELL International, Inc. are deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
CRYO CELL INTERNATIONAL INC
700 BROOKER CREEK BLVD., SUITE 1800
OLDSMAR, FL 34677

X

PORTNOY DAVID
700 BROOKER CREEK BLVD., SUITE 1800
OLDSMAR, FL 34677

X

Portnoy Mark L.
700 BROOKER CREEK BLVD.
ST. 1800
OLDSMAR, FL 34677

X

Gaines George
700 BROOKER CREEK BLVD., SUITE 1800
OLDSMAR, FL 34677

X


Signatures
/s/ David Portnoy, Individual, and Chief Executive Officer and Authorized Representative of Cryo-Cell, International, Inc. 2/21/2018
** Signature of Reporting Person Date

/s/ David Portnoy 2/21/2018
** Signature of Reporting Person Date

/s/ Mark Portnoy 2/21/2018
** Signature of Reporting Person Date

/s/ George Gaines 2/21/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.